TRIALO PTE. LTD.

Trialo is transforming drug development through AI-powered clinical evidence intelligence. Our platform automatically extracts and analyzes efficacy endpoints from regulatory submissions, scientific literature, company announcements, and public documents—enabling pharmaceutical companies, investors, and research organi

Operating in biotech, ai, pharmaceutical based in Singapore, TRIALO PTE. LTD. was founded in 2025.

Profile

Trialo is transforming drug development through AI-powered clinical evidence intelligence. Our platform automatically extracts and analyzes efficacy endpoints from regulatory submissions, scientific literature, company announcements, and public documents—enabling pharmaceutical companies, investors, and research organizations to make faster, more confident development decisions.

TRIALO PTE. LTD. is positioned in biotech, ai, pharmaceutical, a segment that rewards a clear, focused offering.

The business is associated with Singapore.

Directory data places it at the Startup SG directory startup stage.

Its team size is recorded as 1 - 10 employees.

Website: trialo.com